[{"bbox": [91, 99, 369, 132], "category": "Page-header", "text": "Q-Line Biotech Limited"}, {"bbox": [91, 170, 1560, 235], "category": "Text", "text": "Fiscals 2025, 2024 and 2023, our top 10 clients contributed 82.17%, 77.28%, and 76.57% respectively, to the total revenue from operations."}, {"bbox": [91, 265, 407, 298], "category": "Section-header", "text": "9. Competitive conditions"}, {"bbox": [91, 329, 1560, 395], "category": "Text", "text": "Competitive conditions are as described under the Chapters “Industry Overview” and “Our Business” beginning on pages 103 and 123, respectively of this Draft Red Herring Prospectus."}, {"bbox": [91, 425, 1146, 458], "category": "Section-header", "text": "10. Details of material developments after the date of last balance sheet i.e. March 31, 2025"}, {"bbox": [91, 489, 1560, 550], "category": "Text", "text": "Except as mentioned below, there is no material development that has taken effect after the date of last Balance sheet i.e. March 31, 2025 –"}, {"bbox": [91, 584, 1560, 681], "category": "List-item", "text": "1. We have appointed Pravir Kumar as the Non-Executive Independent Director of the Company for a term of 5 years with effect from May 08, 2025 which is approved by the Board in the Board Meeting held on May 06, 2025 and by the shareholders of the Company from May 08, 2025 by way of Ordinary Resolution vide Extra Ordinary General Meeting held on May 08, 2025."}, {"bbox": [91, 681, 1560, 777], "category": "List-item", "text": "2. We have appointed Abhishek Mishra as the Non-Executive Independent Director of the Company for a term of 5 years with effect from May 08, 2025 which is approved by the Board in the Board Meeting held on May 06, 2025 and by the shareholders of the Company from May 08, 2025 by way of Ordinary Resolution vide Extra Ordinary General Meeting held on May 08, 2025."}, {"bbox": [91, 777, 1560, 873], "category": "List-item", "text": "3. We have appointed Rohit Nandan as the Non-Executive Independent Director of the Company for a term of 5 years with effect from May 08, 2025 which is approved by the Board in the Board Meeting held on May 06, 2025 and by the shareholders of the Company from May 08, 2025 by way of Ordinary Resolution vide Extra Ordinary General Meeting held on May 08, 2025."}, {"bbox": [91, 873, 1560, 998], "category": "List-item", "text": "4. We have appointed Jai Prakash Singh as the Non-Executive Independent Director of the Company for a term of 5 years with effect from August 01, 2025 which is approved by the Board in the Board Meeting held on July 25, 2025 and by the shareholders of the Company from August 01, 2025 by way of Ordinary Resolution vide Extra Ordinary General Meeting held on August 01, 2025."}, {"bbox": [91, 998, 1560, 1095], "category": "List-item", "text": "5. We have appointed Saurabh Garg as the Chairman and Managing Director of the Company for a term of 3 years with effect from August 01, 2025 by the board in its meeting held on July 25, 2025 and confirmed by the shareholders in Extra Ordinary General Meeting held on August 01, 2025."}, {"bbox": [91, 1095, 1560, 1192], "category": "List-item", "text": "6. We have appointed Kuldeep Chowdhry as Whole time Director of the Company for a term of 3 years with effect from August 01, 2025 by the board in its meeting held on July 25, 2025 and confirmed by the shareholders in Extra Ordinary General Meeting held on August 01, 2025."}, {"bbox": [91, 1192, 1560, 1257], "category": "List-item", "text": "7. We have appointed Meenal Gupta as the Chief Financial Officer (CFO) of the Company with effect from July 25, 2025 approved by the board in its meeting held on August 25, 2025."}, {"bbox": [91, 1257, 1560, 1321], "category": "List-item", "text": "8. We have appointed Akhand Pratap Singh as the Company Secretary & Compliance Officer of the Company with effect from July 25, 2025 approved by the board in its meeting held on July 25, 2025."}, {"bbox": [91, 1321, 1560, 1417], "category": "List-item", "text": "9. We have appointed Prabhakara Subraya Yethadka as Whole time Director of the Company for a term of 3 years with effect from May 08, 2025 by the board in its meeting held on May 06, 2025 and confirmed by the shareholders in Extra Ordinary General Meeting held on May 08, 2025."}, {"bbox": [91, 1417, 1560, 1480], "category": "List-item", "text": "10. We have changed the category of Abhay Agrawal from Professional to Promoter w.e.f. July 25, 2025 by the board in its board meeting held on July 25, 2025."}, {"bbox": [91, 1480, 1560, 1545], "category": "List-item", "text": "11. We have changed the designation of Ayush Garg from Executive Director to Non-Executive director and change in category from professional to promoter w.e.f. July 25, 2025 by the board in its board meeting held on July 25, 2025."}, {"bbox": [91, 1545, 1560, 1640], "category": "List-item", "text": "12. We have appointed Ajay Kumar Mahanty as Whole time Director of the Company for a term of 3 years with effect from August 01, 2025 by the board in its meeting held on July 25, 2025 and confirmed by the shareholders in Extra Ordinary General Meeting held on August 01, 2025."}, {"bbox": [91, 1640, 1560, 1736], "category": "List-item", "text": "13. We have increased the authorized share capital from Rs. 400.00 Lakh divided into 40,00,000 Equity Shares of Rs. 10/- each to Rs. 2500.00 Lakh divided into 2,50,00,000 Equity Shares of Rs. 10/- each vide Extra Ordinary General Meeting held on August 01, 2025."}, {"bbox": [91, 1736, 1560, 1863], "category": "List-item", "text": "14. We have approved the issue of Bonus Shares to the shareholders of the Company in the ratio of 9:1 by the board in its meeting held on August 26, 2025 and confirmed by the shareholders vide Extra Ordinary General Meeting held on August 28, 2025 and we have allotted Bonus Shares to the shareholders of the Company in the ratio of 9:1 approved by the board in its meeting held on August 28, 2025."}, {"bbox": [91, 1863, 1560, 1960], "category": "List-item", "text": "15. We have approved the issue on Right basis to the shareholders of the Company in the board meeting held on September 16, 2025 and we have allotted 5,24,999 Equity Shares at Par to the new shareholders of the Company in the board in its meeting held on September 27, 2025."}, {"bbox": [91, 1960, 1560, 2024], "category": "List-item", "text": "16. We have passed a Board resolution in the meeting of the Board of Directors held on September 27, 2024 authorizing the Board of Directors to raise funds by making an Initial Public Offering."}, {"bbox": [91, 2024, 1560, 2089], "category": "List-item", "text": "17. We have passed a special resolution in the Extra Ordinary General meeting held on September 27, 2024 authorizing the Board of Directors to raise funds by making an Initial Public Offering."}, {"bbox": [91, 2089, 1560, 2153], "category": "List-item", "text": "18. Our Company has approved the Restated Financial Statements for the financial year ended March 31, 2025, 2024 and 2023 in the Board meeting dated September 24, 2024."}]